Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months. Moderna shares fell 2% in ...

Moderna, Inc. (NASDAQ ... Overall, MRNA ranks 5th on our list of Goldman Sachs' top growth investors. While we acknowledge the potential of MRNA as an investment, our conviction lies in the ...

"Our headquarters is in New York City," said Rob Kaplan, vice chairman of Goldman Sachs. "There are no plans to change that.” ...

Hedge funds returned into markets last week to buy bank stocks having sold out of positions for eight straight weeks, a ...

Goldman Sachs Group Inc.’s executive pay proposal won majority support from shareholders despite criticism the bonuses were ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of reciprocal tariffs later this week.

Adamczyk joined Goldman Sachs in 2024 as advisory chairman of private investments and operations following a 16-year stint at ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

Goldman Sachs updated its recession forecast on Sunday to increase the probability of a recession amid President Donald Trump's tariff war, adding that its analysis may be downgraded further if ...